The Gross Margin of Lincoln Pharmaceuticals Ltd (LINCOLN.NS) is 49.79%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-03-31 | 49.79% |
| 2023-03-31 | 50.36% |
| 2022-03-31 | 51.68% |
| 2021-03-31 | 51.32% |
| 2020-03-31 | 50.34% |
| 2019-03-31 | 49.84% |
| 2018-03-31 | 46.48% |
| 2017-03-31 | 39.05% |
| 2016-03-31 | 30.66% |
| 2015-03-31 | 32.51% |